Key result
Deferred stenting in high-thrombus STEMI boosts TIMI III flow ~27% vs immediate stenting.
Why the study?
The optimal timing of stent implantation in STEMI with high thrombus burden remains uncertain, as immediate stenting risks distal embolization and no-reflow while deferred stenting may improve microvascular recovery.
Does deferred stenting improve angiographic reperfusion and left ventricular function in STEMI patients with high thrombus burden compared to immediate stenting?
RCT (n=115)
randomized
Does deferred stenting improve angiographic reperfusion and left ventricular function in STEMI patients with high thrombus burden compared to immediate stenting?
Deferred stenting in STEMI patients with high thrombus burden improves angiographic reperfusion and left ventricular function recovery, though it does not significantly reduce short-term MACE.
Answers are grounded in this paper and cite their sources.
Supports deferred stenting in high-thrombus STEMI; extends RCT evidence for staged intervention.
Objectives: The optimal timing of stent implantation in ST-segment elevation myocardial infarction (STEMI) with high thrombus burden remains uncertain. Immediate stenting carries a risk of distal embolization and no-reflow, whereas deferred stenting may facilitate improved microvascular recovery. This study compared angiographic and echocardiographic outcomes of immediate versus deferred stenting using three-dimensional speckle tracking echocardiography (3D-STE). Materials and Methods: In this randomized clinical trial, 115 STEMI patients with high thrombus burden were allocated to immediate stenting ( n = 60) or deferred stenting after dual antiplatelet therapy plus enoxaparin ( n = 55). Primary endpoints were final thrombolysis in myocardial infarction (TIMI) flow, myocardial blush grade (MBG), and left ventricular ejection fraction (LVEF) by 3D-STE. Secondary endpoints included global strain parameters and major adverse cardiovascular events (MACE) at 6 months. Results: Deferred stenting achieved higher TIMI III flow (76.4% vs. 60.0%, P < 0.001) and MBG 3 (63.6% vs. 41.7%, P = 0.0025). Both groups showed improved LVEF at 6 months, with greater gains in the deferred group (EF change: 14.05% vs. 12.89%, P = 0.043). Favorable but nonsignificant trends were noted in global longitudinal, circumferential, and radial strain. MACE rates were similar between groups (34.5% vs. 41.7%, P = 0.45). Conclusions: Deferred stenting in STEMI patients with high thrombus burden enhanced angiographic reperfusion and improved recovery of left ventricular function without reducing short-term MACE. These findings suggest deferred stenting as a feasible strategy to optimize myocardial reperfusion, warranting larger, long-term trials to evaluate its prognostic impact.
No takes yet. Share an insight, caveat, or question.
Eldamanhory et al. (2026) conducted an RCT in ST-segment elevation myocardial infarction (STEMI) with high thrombus burden (n=115). Deferred stenting vs. Immediate stenting was evaluated on final thrombolysis in myocardial infarction (TIMI) III flow (p=< 0.001). Deferred stenting in STEMI patients with high thrombus burden achieved higher TIMI III flow and MBG 3 compared to immediate stenting.
Synapse has enriched 10 related papers. Consider them for comparative context: